231 related articles for article (PubMed ID: 15199115)
1. Bone sialoprotein, matrix metalloproteinase 2, and alpha(v)beta3 integrin in osteotropic cancer cell invasion.
Karadag A; Ogbureke KU; Fedarko NS; Fisher LW
J Natl Cancer Inst; 2004 Jun; 96(12):956-65. PubMed ID: 15199115
[TBL] [Abstract][Full Text] [Related]
2. Bone sialoprotein enhances migration of bone marrow stromal cells through matrices by bridging MMP-2 to alpha(v)beta3-integrin.
Karadag A; Fisher LW
J Bone Miner Res; 2006 Oct; 21(10):1627-36. PubMed ID: 16995818
[TBL] [Abstract][Full Text] [Related]
3. Bone sialoprotein supports breast cancer cell adhesion proliferation and migration through differential usage of the alpha(v)beta3 and alpha(v)beta5 integrins.
Sung V; Stubbs JT; Fisher L; Aaron AD; Thompson EW
J Cell Physiol; 1998 Sep; 176(3):482-94. PubMed ID: 9699501
[TBL] [Abstract][Full Text] [Related]
4. Bone sialoprotein stimulates focal adhesion-related signaling pathways: role in migration and survival of breast and prostate cancer cells.
Gordon JA; Sodek J; Hunter GK; Goldberg HA
J Cell Biochem; 2009 Aug; 107(6):1118-28. PubMed ID: 19492334
[TBL] [Abstract][Full Text] [Related]
5. Bone sialoprotein does not interact with pro-gelatinase A (MMP-2) or mediate MMP-2 activation.
Hwang Q; Cheifetz S; Overall CM; McCulloch CA; Sodek J
BMC Cancer; 2009 Apr; 9():121. PubMed ID: 19386107
[TBL] [Abstract][Full Text] [Related]
6. Dentin matrix protein 1 enhances invasion potential of colon cancer cells by bridging matrix metalloproteinase-9 to integrins and CD44.
Karadag A; Fedarko NS; Fisher LW
Cancer Res; 2005 Dec; 65(24):11545-52. PubMed ID: 16357164
[TBL] [Abstract][Full Text] [Related]
7. Dissecting the role of matrix metalloproteinases (MMP) and integrin alpha(v)beta3 in angiogenesis in vitro: absence of hemopexin C domain bioactivity, but membrane-Type 1-MMP and alpha(v)beta3 are critical.
Nisato RE; Hosseini G; Sirrenberg C; Butler GS; Crabbe T; Docherty AJ; Wiesner M; Murphy G; Overall CM; Goodman SL; Pepper MS
Cancer Res; 2005 Oct; 65(20):9377-87. PubMed ID: 16230401
[TBL] [Abstract][Full Text] [Related]
8. BSP gene silencing inhibits migration, invasion, and bone metastasis of MDA-MB-231BO human breast cancer cells.
Wang J; Wang L; Xia B; Yang C; Lai H; Chen X
PLoS One; 2013; 8(5):e62936. PubMed ID: 23667544
[TBL] [Abstract][Full Text] [Related]
9. SB225002 inhibits prostate cancer invasion and attenuates the expression of BSP, OPN and MMP‑2.
Xu M; Jiang H; Wang H; Liu J; Liu B; Guo Z
Oncol Rep; 2018 Aug; 40(2):726-736. PubMed ID: 29917166
[TBL] [Abstract][Full Text] [Related]
10. Bone sialoprotein-αvβ3 integrin axis promotes breast cancer metastasis to the bone.
Wang L; Song L; Li J; Wang Y; Yang C; Kou X; Xiao B; Zhang W; Li L; Liu S; Wang J
Cancer Sci; 2019 Oct; 110(10):3157-3172. PubMed ID: 31432600
[TBL] [Abstract][Full Text] [Related]
11. Alpha-V-dependent outside-in signaling is required for the regulation of CD44 surface expression, MMP-2 secretion, and cell migration by osteopontin in human melanoma cells.
Samanna V; Wei H; Ego-Osuala D; Chellaiah MA
Exp Cell Res; 2006 Jul; 312(12):2214-30. PubMed ID: 16631740
[TBL] [Abstract][Full Text] [Related]
12. Bone sialoprotein binding to matrix metalloproteinase-2 alters enzyme inhibition kinetics.
Jain A; Fisher LW; Fedarko NS
Biochemistry; 2008 Jun; 47(22):5986-95. PubMed ID: 18465841
[TBL] [Abstract][Full Text] [Related]
13. Coexpression of integrin alpha(v)beta3 and matrix metalloproteinase-2 (MMP-2) coincides with MMP-2 activation: correlation with melanoma progression.
Hofmann UB; Westphal JR; Waas ET; Becker JC; Ruiter DJ; van Muijen GN
J Invest Dermatol; 2000 Oct; 115(4):625-32. PubMed ID: 10998134
[TBL] [Abstract][Full Text] [Related]
14. The type I collagen induction of MT1-MMP-mediated MMP-2 activation is repressed by alphaVbeta3 integrin in human breast cancer cells.
Borrirukwanit K; Lafleur MA; Mercuri FA; Blick T; Price JT; Fridman R; Pereira JJ; Leardkamonkarn V; Thompson EW
Matrix Biol; 2007 May; 26(4):291-305. PubMed ID: 17175151
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of SIBLING proteins and correlation with cognate MMP expression in oral cancer.
Ogbureke KU; Nikitakis NG; Warburton G; Ord RA; Sauk JJ; Waller JL; Fisher LW
Oral Oncol; 2007 Oct; 43(9):920-32. PubMed ID: 17306612
[TBL] [Abstract][Full Text] [Related]
16. Integrin alpha(v)beta3 expression confers on tumor cells a greater propensity to metastasize to bone.
Pécheur I; Peyruchaud O; Serre CM; Guglielmi J; Voland C; Bourre F; Margue C; Cohen-Solal M; Buffet A; Kieffer N; Clézardin P
FASEB J; 2002 Aug; 16(10):1266-8. PubMed ID: 12153995
[TBL] [Abstract][Full Text] [Related]
17. Integrin-linked kinase regulates osteopontin-dependent MMP-2 and uPA expression to convey metastatic function in murine mammary epithelial cancer cells.
Mi Z; Guo H; Wai PY; Gao C; Kuo PC
Carcinogenesis; 2006 Jun; 27(6):1134-45. PubMed ID: 16474180
[TBL] [Abstract][Full Text] [Related]
18. Molecular determinants of glioma cell migration and invasion.
Wild-Bode C; Weller M; Wick W
J Neurosurg; 2001 Jun; 94(6):978-84. PubMed ID: 11409528
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of bone sialoprotein in bone metastases compared with visceral metastases in human breast and prostate cancers.
Waltregny D; Bellahcène A; de Leval X; Florkin B; Weidle U; Castronovo V
J Bone Miner Res; 2000 May; 15(5):834-43. PubMed ID: 10804012
[TBL] [Abstract][Full Text] [Related]
20. Increased invasive potential and up-regulation of MMP-2 in MDA-MB-231 breast cancer cells expressing the beta3 integrin subunit.
Baum O; Hlushchuk R; Forster A; Greiner R; Clézardin P; Zhao Y; Djonov V; Gruber G
Int J Oncol; 2007 Feb; 30(2):325-32. PubMed ID: 17203213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
